cynthia_chiaramitara

Novartis elects new MD for UK plant

pharmafile | October 28, 2016 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Novartis, appointment 

Novartis has named Cynthia Chiaramitara as managing director of its plant in Grimsby, UK.

She will take on the role starting 1 January. Current MD Anne Wirtz will leave her position to join the head office in Basel, Switzerland.

Novartis, who last month celebrated its 20th year, recruited Chiaramitara in 2004. Prior to joining the company, she worked in a range of positions across a number of multi-national organisations, taking the title of process manager and process unit head in Brazuil. Chiaramitara was later relocated to Basel where she assumed the role of global relations head for chemical operations, and later for the Aseptics platform.

Advertisement

Matt Fellows

Related Content

Novartis receives SMC approval for early breast cancer treatment

Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval …

drug-trials

Novartis candidate for Sjögren’s disease presents positive results

Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 …

Mosquito image

First malaria medicine for infants under 4.5kg receives approval

Coartem (artemether-lumefantrine) Baby, or Riamet, has been approved by Swissmedic as the first malaria medicine …

The Gateway to Local Adoption Series

Latest content